+91 92688 80303
+91 92688 80303
Top Canavan disease Doctors in India
To Book an Appointment
Call Us+91 92688 80303Filters
Doctors Available
Can't find what you are looking for?
Conditions are an all-encompassing term for all diseases, disorders and illnesses. Above doctors at Max Hospital, India are the top specialists for Canavan disease in India, India. Book a video consultation or in-hospital appointment to receive the best treatments with cutting edge technology. Learn more about Canavan disease doctors’ qualification, background, specialization and experience. Book doctor appointments online, check OPD timings at one of the best hospitals in Max Hospital, India.
Frequently Asked Questions
Canavan disease is a rare genetic disorder that affects the development of the brain. It is caused by a mutation in the ASPA gene, which leads to the accumulation of a substance called N-acetyl-L-aspartic acid (NAA) in the brain.
Canavan disease is inherited in an autosomal recessive manner, which means that both parents must carry a mutated ASPA gene and pass it on to their child for the disease to develop.
The symptoms of Canavan disease usually appear in early infancy and may include poor muscle tone, developmental delays, feeding difficulties, seizures, and an abnormally large head (macrocephaly).
Canavan disease can be diagnosed through genetic testing, which looks for mutations in the ASPA gene. MRI of the brain can show characteristic abnormalities associated with the disease.
Currently, there is no cure for Canavan disease. Treatment mainly focuses on managing the symptoms.
Treatment options for Canavan disease are limited. Supportive care, such as physical therapy and occupational therapy, can help manage symptoms and improve mobility. Medications may be used to control seizures and other associated complications.
The life expectancy for individuals with Canavan disease varies. In severe cases, life expectancy may be reduced, while individuals with milder forms of the disease may have a normal lifespan.
Yes, prenatal testing is available for Canavan disease. It involves analysing a sample of cells from the fetus to determine if they carry the ASPA gene mutation.
Carriers of Canavan disease typically do not have symptoms themselves. The condition only manifests if both copies of the ASPA gene are mutated.
The primary risk factor for Canavan disease is having Ashkenazi Jewish ancestry. The mutation in the ASPA gene is more common in this population.
In some regions, Canavan disease is included in newborn screening programs. The screening involves testing a small blood sample from the baby to identify genetic conditions, including Canavan disease.
The ability of individuals with Canavan disease to attend school depends on the severity of their symptoms and the level of support available. In some cases, specialised educational programs may be necessary.
Canavan disease is typically diagnosed in infancy or early childhood due to the appearance of symptoms.
Canavan disease primarily affects the brain and its development. It does not typically involve other organs in the body.
The ASPA gene provides instructions for producing an enzyme called aspartoacylase. Mutations in this gene result in reduced or absent aspartoacylase activity, leading to the accumulation of N-acetyl-L-aspartic acid (NAA) in the brain.
Canavan disease is an autosomal recessive disorder, which means that both parents must carry a mutated ASPA gene and pass it on to their child for the disease to develop.
FAQs reviewed by Dr. Manoj Khanal, Associate Director, Neurosciences, Neurology, Interventional Neurology.